UC Davis medical school among nation’s best in NIH funding
Blue Ridge ranking reflects leadership in federal research support of medical innovation, health discovery
The UC Davis School of Medicine is among the nation’s leading medical schools in National Institutes of Health (NIH) research funding. In The latest ranking by Blue Ridge Institute for Medical Research, the medical school placed 31st nationally, two spots higher than last year, and with a record total of $233 million in NIH grants.
“I couldn’t be prouder of our outstanding faculty researchers who, in a challenging funding environment, have gone above and beyond in submitting a record number of successful grant proposals," said School of Medicine Dean Susan Murin. "It is a testament to their commitment to science, to UC Davis and to our patients.”
Twelve departments in the Top 20
This year, 12 School of Medicine departments ranked in the top 20 nationally in their respective fields, two of which are in the top 10. They include:
- Public Health Sciences #3
- Neurology #6
- Medical Microbiology and Immunology #11
- Cell Biology and Human Anatomy #12
- Physiology and Membrane Biology #12
- Neurosurgery #14
- Physical Medicine and Rehabilitation #15
- Dermatology #15
- Urologic Surgery #16
- Biochemistry and Molecular Medicine #17
- Emergency Medicine #17
- Pharmacology #19
The top three departments in overall NIH funding were Neurology (nearly $38 million), Public Health Sciences ($30.8 million) and Internal Medicine ($26.3 million). All UC Davis basic science departments ranked in the top 20 nationally.
Top NIH-funded principal investigators and centers
This fiscal year, 262 principal investigators (PIs) were awarded 383 NIH grants. The following is a list of the top 10 PIs for NIH funding.
For the third year in a row, professor Rachel Whitmer is the PI with the largest NIH funding at UC Davis and in public health sciences nationwide, with a total of about $13.4 million. She co-directs the Alzheimer’s Disease Research Center (ADRC), studies age-related dementia, cognitive impairment and brain pathology among different ethnic groups.
Charles DeCarli, co-director of the ADRC and a distinguished professor in the Department of Neurology, is the PI for $12.5 million in funding. The grant for his study on incidental white matter lesions on MRI amongst people with cognitive complaints (INDEED) is the highest NIH grant ($9.3 million) for UC Davis.
Dennis Hartigan-O’Connor, a professor in the Department of Medical Microbiology and Immunology, is the PI for $6.1 million in NIH support. He studies immunotherapies for chronic infections, autoimmunity and cancer.
Peter James’ $5.1 million NIH grant explores environmental exposures and brain health. James is an associate professor in the Department of Public Health Sciences and director of Center for Occupational and Environmental Health.
Cynthia Schumann is the PI on $3.2 million in NIH grants to study changes in primate brain development after prenatal immune challenge, and brain aging across the lifespan in neurodevelopmental disorders. Schumann is a professor of neuroscience and faculty affiliated with the UC Davis MIND Institute. She is the director of the Brain Endowment for Autism Research Sciences (BEARS) and Brain Endowment for Mental Health (BEMH).
Rebecca Schmidt, professor in the Department of Public Health Sciences and the MIND Institute, is the PI for grants totaling $3.1 million. She leads BUILDS MARBLES, a longitudinal study of pregnant women who have an autistic child, and prenatal environment and child health (PEACH) study in ECHO. She also studies the molecular and neurodevelopmental changes linked to prenatal wildfire exposures.
Four PIs manage grants that support leading UC Davis centers and programs:
- KC Kent Lloyd ($5.7 million): The UC Davis Mouse Biology Program,
- Ted Wun ($5.1 million): The Clinical and Translational Science Center (CTSC),
- Primo Lara ($4.4 million): The UC Davis Comprehensive Cancer Center,
- Alice Tarantal ($4.3 million): the Primate Center for Gene Therapy.
“I’m delighted to see the School of Medicine continue its advance in the Blue Ridge rankings. I am particularly proud of the record number of our departments who are now in the top 20 for their respective disciplines,” said Kim E. Barrett, vice dean for research and distinguished professor of physiology and membrane biology. “This year also includes funding for a record number (32) of NIH K awards made to early career researchers. This validates our investments in programs designed to grow new PI’s from within our own ranks and helps to secure our future success.”
In May 2025, Aggie Square opened as a first-of-its-kind innovation district on the UC Davis Sacramento campus. The district brings together UC Davis researchers and students, industry partners, entrepreneurs and the community to work side-by-side to accelerate ideas and bring them into the world. It is home to many School of Medicine research labs.
Learn about some of the impactful federally-funded research that drives innovation from labs to lives.
